170 related articles for article (PubMed ID: 14672957)
21. Arylamine N-acetyltransferase activity in bronchial epithelial cells and its inhibition by cellular oxidants.
Dairou J; Petit E; Ragunathan N; Baeza-Squiban A; Marano F; Dupret JM; Rodrigues-Lima F
Toxicol Appl Pharmacol; 2009 May; 236(3):366-71. PubMed ID: 19248797
[TBL] [Abstract][Full Text] [Related]
22. Identification of cancer chemopreventive isothiocyanates as direct inhibitors of the arylamine N-acetyltransferase-dependent acetylation and bioactivation of aromatic amine carcinogens.
Duval R; Xu X; Bui LC; Mathieu C; Petit E; Cariou K; Dodd RH; Dupret JM; Rodrigues-Lima F
Oncotarget; 2016 Feb; 7(8):8688-99. PubMed ID: 26840026
[TBL] [Abstract][Full Text] [Related]
23. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes.
Grant DM; Blum M; Beer M; Meyer UA
Mol Pharmacol; 1991 Feb; 39(2):184-91. PubMed ID: 1996083
[TBL] [Abstract][Full Text] [Related]
24. Probing the mechanism of hamster arylamine N-acetyltransferase 2 acetylation by active site modification, site-directed mutagenesis, and pre-steady state and steady state kinetic studies.
Wang H; Vath GM; Gleason KJ; Hanna PE; Wagner CR
Biochemistry; 2004 Jun; 43(25):8234-46. PubMed ID: 15209520
[TBL] [Abstract][Full Text] [Related]
25. Longitudinal distribution of arylamine N-acetyltransferases in the intestine of the hamster, mouse, and rat. Evidence for multiplicity of N-acetyltransferases in the intestine.
Ware JA; Svensson CK
Biochem Pharmacol; 1996 Nov; 52(10):1613-20. PubMed ID: 8937477
[TBL] [Abstract][Full Text] [Related]
26. Inhibitory effects of polyphenolic compounds on human arylamine N-acetyltransferase 1 and 2.
Kukongviriyapan V; Phromsopha N; Tassaneeyakul W; Kukongviriyapan U; Sripa B; Hahnvajanawong V; Bhudhisawasdi V
Xenobiotica; 2006 Jan; 36(1):15-28. PubMed ID: 16507510
[TBL] [Abstract][Full Text] [Related]
27. Placental expression of arylamine N-acetyltransferases: evidence for linkage disequilibrium between NAT1*10 and NAT2*4 alleles of the two human arylamine N-acetyltransferase loci NAT1 and NAT2.
Smelt VA; Mardon HJ; Sim E
Pharmacol Toxicol; 1998 Oct; 83(4):149-57. PubMed ID: 9820875
[TBL] [Abstract][Full Text] [Related]
28. Generation and functional characterization of arylamine N-acetyltransferase Nat1/Nat2 double-knockout mice.
Sugamori KS; Wong S; Gaedigk A; Yu V; Abramovici H; Rozmahel R; Grant DM
Mol Pharmacol; 2003 Jul; 64(1):170-9. PubMed ID: 12815173
[TBL] [Abstract][Full Text] [Related]
29. Chemical modification of hamster arylamine N-acetyltransferase 2 with isozyme-selective and nonselective N-arylbromoacetamido reagents.
Wang H; Guo Z; Vath GM; Wagner CR; Hanna PE
Protein J; 2004 Feb; 23(2):153-66. PubMed ID: 15106881
[TBL] [Abstract][Full Text] [Related]
30. CRISPR/Cas9 knockout of human arylamine N-acetyltransferase 1 in MDA-MB-231 breast cancer cells suggests a role in cellular metabolism.
Carlisle SM; Trainor PJ; Hong KU; Doll MA; Hein DW
Sci Rep; 2020 Jun; 10(1):9804. PubMed ID: 32555504
[TBL] [Abstract][Full Text] [Related]
31. Molecular and Functional Characterization of N-Acetyltransferases NAT1 and NAT2 in Cynomolgus Macaque.
Uno Y; Murayama N; Yamazaki H
Chem Res Toxicol; 2018 Nov; 31(11):1269-1276. PubMed ID: 30358977
[TBL] [Abstract][Full Text] [Related]
32. Genetic and small molecule inhibition of arylamine N-acetyltransferase 1 reduces anchorage-independent growth in human breast cancer cell line MDA-MB-231.
Stepp MW; Doll MA; Carlisle SM; States JC; Hein DW
Mol Carcinog; 2018 Apr; 57(4):549-558. PubMed ID: 29315819
[TBL] [Abstract][Full Text] [Related]
33. Mass spectrometric investigation of the mechanism of inactivation of hamster arylamine N-acetyltransferase 1 by N-hydroxy-2-acetylaminofluorene.
Guo Z; Wagner CR; Hanna PE
Chem Res Toxicol; 2004 Mar; 17(3):275-86. PubMed ID: 15025497
[TBL] [Abstract][Full Text] [Related]
34. Arylamine N-acetyltransferases: characterization of the substrate specificities and molecular interactions of environmental arylamines with human NAT1 and NAT2.
Liu L; Von Vett A; Zhang N; Walters KJ; Wagner CR; Hanna PE
Chem Res Toxicol; 2007 Sep; 20(9):1300-8. PubMed ID: 17672512
[TBL] [Abstract][Full Text] [Related]
35. Identification and characterization of functional rat arylamine N-acetyltransferase 3: comparisons with rat arylamine N-acetyltransferases 1 and 2.
Walraven JM; Doll MA; Hein DW
J Pharmacol Exp Ther; 2006 Oct; 319(1):369-75. PubMed ID: 16829624
[TBL] [Abstract][Full Text] [Related]
36. Effect of environmental substances on the activity of arylamine N-acetyltransferases.
Rodrigues-Lima F; Dairou J; Dupret JM
Curr Drug Metab; 2008 Jul; 9(6):505-9. PubMed ID: 18680470
[TBL] [Abstract][Full Text] [Related]
37. N-Acetyltransferases, sulfotransferases and heterocyclic amine activation in the breast.
Williams JA; Stone EM; Fakis G; Johnson N; Cordell JA; Meinl W; Glatt H; Sim E; Phillips DH
Pharmacogenetics; 2001 Jul; 11(5):373-88. PubMed ID: 11470991
[TBL] [Abstract][Full Text] [Related]
38. Identification of amino acids imparting acceptor substrate selectivity to human arylamine acetyltransferases NAT1 and NAT2.
Goodfellow GH; Dupret JM; Grant DM
Biochem J; 2000 May; 348 Pt 1(Pt 1):159-66. PubMed ID: 10794727
[TBL] [Abstract][Full Text] [Related]
39. Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis.
Hein DW
Mutat Res; 2002 Sep; 506-507():65-77. PubMed ID: 12351146
[TBL] [Abstract][Full Text] [Related]
40. Regulation of the activity of the human drug metabolizing enzyme arylamine N-acetyltransferase 1: role of genetic and non genetic factors.
Rodrigues-Lima F; Dupret JM
Curr Pharm Des; 2004; 10(20):2519-24. PubMed ID: 15320760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]